Miracle Biomedical
CompanyTaiwan
Miracle Biomedical develops one asset, in phase 1 (MiraMSC in frailty). Mostly cell therapy; based in Taiwan.
- 1
- Asset
- Furthest stage
- Phase 1
- 1
- Trial
- 0
- Signals
Pipeline
1Allogeneic umbilical cord-derived mesenchymal stem cell therapy intended to treat frailty.
Phase 1, Cell therapy, frailty
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Trials1
- Signals1
- Similar companies6